Edwards calls off JenaValve buyout after court halts deal [Yahoo! Finance]
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Yahoo! Finance
Edwards Lifesciences said Friday it has dropped plans to acquire JenaValve Technology after a U.S. district court granted the Federal Trade Commission's motion for an injunction blocking the transaction. Edwards said it disagrees with the ruling, in the U.S. District Court for the District of Columbia, and believes the acquisition would have been in the best interest of a large underserved group of patients. As a result of the decision, Edwards revised its full-year 2026 adjusted per-share earnings forecast to a range of $2.90 to $3.05, up from earlier guidance of $2.80 to $2.95. In August, the FTC challenged Edwards' planned $945 million purchase of JenaValve, citing concerns that the acquisition would limit patient access to devices to treat aortic regurgitation, a potentially fatal heart condition. The move came roughly a year after Edwards announced the deal The FTC argued that Edwards' purchase of JenaValve would combine the only two companies conducting U.S. clinical tr
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Edwards Lifesciences (NYSE:EW) had its "neutral" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Edwards Lifesciences (NYSE:EW) was given a new $90.00 price target on by analysts at Robert W. Baird.MarketBeat
- Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Edwards Comments on JenaValve Acquisition [Yahoo! Finance]Yahoo! Finance
- Edwards Comments on JenaValve AcquisitionBusiness Wire
EW
Earnings
- 10/30/25 - Beat
EW
Sec Filings
- 1/12/26 - Form 8-K
- 1/9/26 - Form 4
- 1/6/26 - Form 4
- EW's page on the SEC website